Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment-Reference-Cited by-同舟云学术

Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment

Published:2020-10 Issue:4 Volume:98 Page:839-848
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

de Boer Ian H.,Caramori M. Luiza,Chan Juliana C.N.,Heerspink Hiddo J.L.,Hurst Clint,Khunti Kamlesh,Liew Adrian,Michos Erin D.,Navaneethan Sankar D.,Olowu Wasiu A.,Sadusky Tami,Tandon Nikhil,Tuttle Katherine R.,Wanner Christoph,Wilkens Katy G.,Zoungas Sophia,Lytvyn Lyubov,Craig Jonathan C.,Tunnicliffe David J.,Howell Martin,Tonelli Marcello,Cheung Michael,Earley Amy,Rossing Peter

Publisher

Elsevier BV

Subject

Nephrology

Reference33 articles.

1. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014;Afkarian;JAMA,2016

2. Diabetic kidney disease: challenges, progress, and possibilities;Alicic;Clin J Am Soc Nephrol,2017

3. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology;Guyatt;J Clin Epidemiol,2011

4. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis;Fox;Lancet,2012

5. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes;Rawshani;N Engl J Med,2018

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of Food Recommendation Systems in the Context of Nutritional Therapy for Diabetes Mellitus;Current Nutrition & Food Science;2025-01

2. Use of the Screening for Occult Renal Disease (SCORED) Questionnaire to Screen Diabetic Nephropathy in Asymptomatic Patients: A Cross-Sectional Study;Cureus;2024-08-06

3. Could the administration of SGLT2i agents serve as a viable prophylactic approach against CNI-induced toxicities?;Medical Hypotheses;2024-08

4. Mitigation of ROS-triggered endoplasmic reticulum stress by upregulating Nrf2 retards diabetic nephropathy;Biochemical and Biophysical Research Communications;2024-08

5. Chronic kidney disease in type 2 diabetes: The size of the problem, addressing residual renal risk and what we have learned from the CREDENCE trial;Diabetes, Obesity and Metabolism;2024-07-23